Key points are not available for this paper at this time.
Keywords: vascular endothelial growth factor A, bevacizumab, antiangiogenesis, direct antitumor activity, tumor cells
Wang et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: